Fuzuloparib as maintenance therapy among patients with advanced ovarian cancer after a response to first-line platinum-based chemotherapy: Results from a randomized, placebo-controlled, phase III trial
已完结
10
由 Aixuexi 发布于 2025/12/31 16:37:18
DOI:10.1016/j.ygyno.2024.07.110
作者：Lingying Wu ,?Ning Li ,?Jing Wang ,?Qingshui Li ,?Danbo Wang ,?Junying Tang ,?Cuiying Zhang ,?Guonan Zhang ,?Min Hao ,?Desheng Yao ,?Wei Duan ,?Qinglei Gao ,?Li Wang ,?Youzhong Zhang ,?Ruifang An ,?Ru
文献类型：期刊论文
补充材料：只需要正文
作者：Lingying Wu ,?Ning Li ,?Jing Wang ,?Qingshui Li ,?Danbo Wang ,?Junying Tang ,?Cuiying Zhang ,?Guonan Zhang ,?Min Hao ,?Desheng Yao ,?Wei Duan ,?Qinglei Gao ,?Li Wang ,?Youzhong Zhang ,?Ruifang An ,?Ru
文献类型：期刊论文
补充材料：只需要正文
Elsevier
其它数据库
京公网安备 11010802042870号
